Found: 6
Select item for more details and to access through your institution.
Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus–Coinfected Patients with Advanced Immunosuppression.
- Published in:
- Clinical Infectious Diseases, 2009, v. 49, n. 8, p. e84, doi. 10.1086/605677
- By:
- Publication type:
- Article
Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 11, p. 2605
- By:
- Publication type:
- Article
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 6, p. 1365, doi. 10.1093/jac/dkn420
- By:
- Publication type:
- Article
Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 4, p. 793, doi. 10.1093/jac/dkn262
- By:
- Publication type:
- Article
Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 58, n. 1, p. 140, doi. 10.1093/jac/dkl214
- By:
- Publication type:
- Article
The Use of Transient Elastometry for Assessing Liver Fibrosis in Patients with HIV and Hepatitis C Virus Coinfection.
- Published in:
- Clinical Infectious Diseases, 2007, v. 45, n. 8, p. 969, doi. 10.1086/521857
- By:
- Publication type:
- Article